NCT02823574: Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- State
- Completed
- Phase
- Phase 2
- People
- 425 taking part
- Started
- 8 Nov 2016
- Primary completion
- 23 Jan 2019
- Arms
- Nivolumab and Ipilimumab
- Results
- Posted on the registry
- 6 Jul 2016: Trial registered
- 8 Nov 2016: Trial started
- 21 Apr 2022: Trial completed
- 21 Apr 2022: Trial results posted